Assembly Biosciences Stock Price Patterns
| ASMB Stock | USD 28.12 -0.18 -0.64% |
Momentum
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter -0.60 | EPS Estimate Current Year -3.71 | EPS Estimate Next Year -3.50 | Wall Street Target Price 47.75 | EPS Estimate Current Quarter -0.65 |
This section relates Assembly Biosciences headline activity to recent price behavior and peer context. This view presents sentiment context from Assembly Biosciences' options flow and short interest.
Consult Interest Debt Per Share together with Revenue Per Share for more information.
Assembly Biosciences Implied Volatility | 1.13 |
Assembly Biosciences' implied volatility reflects the market's expectation for price variability, not direction. The indicator is a neutral reference for expected variability.
This hype view for Assembly Biosciences frames attention cycles and how they align with price movement.
Assembly Biosciences after-hype prediction price | $ 28.12 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Rule 16 Reference for the current Assembly contract
Based on Rule 16, the market-implied daily move for 2026-06-18 options is about 0.0706%. The figure is a neutral volatility reference; near $ 28.12, it implies about $ 0.02 per day.
Cross-verify projections for Assembly Biosciences using Assembly Biosciences Basic Forecasting Models. The model set adds a statistical reference.While mean reversion in Assembly Biosciences is a statistically observable tendency, it operates on uncertain timelines. Positions sized too aggressively against the trend can suffer sustained losses before reversion occurs.
After-Hype Price Density Analysis
One key insight from Assembly Biosciences' price distribution analysis is that the most likely single outcome - the mode - is not necessarily the most important. The width and shape of Assembly Biosciences's distribution determine how often extreme deviations from the central forecast occur.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Historical analysis of Assembly Biosciences reveals distinct patterns in how Assembly Biosciences' price responds to different categories of news. Assembly Biosciences' after-hype downside and upside margins for the prediction period are 23.99 and 32.25, respectively. The most informative signals come from news categories where Assembly Biosciences has shown consistent and predictable historical reactions.
Current Value
Macroaxis estimates the after-hype price of Assembly Biosciences across a 3 months horizon to evaluate where the instrument could settle once headline distortion subsides. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Assembly Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Assembly Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Assembly Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 4.14 | 0.09 | 0.00 | 7 Events | 7 Events | In 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
28.12 | 28.12 | 0.00 |
|
Hype Timeline
Assembly Biosciences is presently traded for 28.12. The company has historical hype elasticity of 0.09, and average elasticity to hype of competition of 0.0. Assembly is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at -0.2%. %. The volatility of related hype on Assembly Biosciences is about 20700.0%, with the expected price after the next announcement by competition of 28.12. About 32.0% of the company shares are held by company insiders. The book value of Assembly Biosciences was presently reported as 11.55. The company recorded a loss per share of 4.6. Assembly Biosciences had not issued any dividends in recent years. The company completed a 1:12 stock split on 12th of February 2024. Given the investment horizon of 90 days the next expected press release will be in 7 days. Cross-verify projections for Assembly Biosciences using Assembly Biosciences Basic Forecasting Models. The model set adds a statistical reference.Related Hype Analysis
Tracking the hype elasticity of Assembly Biosciences' direct competitors provides a quantified measure of how much news about other companies in the sector affects Assembly Biosciences's short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZURA | Zura Bio Limited | 0.02 | 12 per month | 4.20 | 0.17 | 9.32 | -7.00 | 33.15 | |
| FHTX | Foghorn Therapeutics | -0.23 | 7 per month | 3.57 | 0.06 | 8.60 | -5.54 | 36.56 | |
| IMRX | Immuneering Corp | -0.04 | 10 per month | 0.00 | -0.01 | 8.12 | -4.93 | 67.18 | |
| SGMT | Sagimet Biosciences Series | -0.24 | 8 per month | 0.00 | -0.03 | 5.78 | -7.32 | 22.02 | |
| ENTA | Enanta Pharmaceuticals | -0.01 | 9 per month | 0.00 | -0.02 | 5.41 | -5.36 | 20.18 | |
| AARD | Aardvark Therapeutics Common | 0.1 | 18 per month | 0.00 | -0.12 | 6.56 | -10.11 | 68.25 | |
| NAUT | Nautilus Biotechnology | 0.25 | 7 per month | 4.58 | 0.07 | 9.29 | -7.21 | 39.09 | |
| ARCT | Arcturus Therapeutics Holdings | 0.36 | 9 per month | 0.00 | -0.02 | 6.53 | -5.23 | 17.23 | |
| PYXS | Pyxis Oncology | 0.02 | 3 per month | 0.00 | -0.11 | 9.49 | -9.40 | 51.54 | |
| TNYA | Tenaya Therapeutics | -0.03 | 10 per month | 0.00 | -0.03 | 8.57 | -10.71 | 47.63 |
Assembly Biosciences Additional Predictive Modules
Most predictive techniques to examine Assembly price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Assembly using various technical indicators. When you analyze Assembly charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Assembly Biosciences evaluates news tone, positioning, and narrative momentum. Optimistic narratives may increase participation during risk-on phases. Assembly Biosciences has a market cap of 444.7 M, ROE of -36.94%.
Data shown for Assembly Biosciences is aggregated from periodic company reporting and market reference feeds and normalized across reporting formats. Source publication cadence can introduce delays.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for Assembly Stock analysis
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |